CMS says 26.9 million beneficiaries are expected to enroll in Medicare Advantage plans in 2021.
Enrollment in Medicare Advantage has been increasing steadily since the early 2000s and the growth will continue next year, according to figures recently announced by CMS
A CMS press release yesterday said 26.9 million Medicare beneficiaries are expected to enroll in Medicare Advantage plans next year, a 10.2% increase from this year’s enrollment of 24.4 million.
The enrollment increase is consistent with the trend of the growing popularity of Medicare Advantage plans relative to traditional fee-for-service Medicare. Enrollment in Medicare Advantage plans has doubled over the past 10 years, according to the Kaiser Family Foundation’s figures. More than a third of Medicare beneficiaries are now in Medicare Advantage plans.
From "A Dozen Facts About Medicare Advantage in 2020," KFF, April 22, 2020.
The CMS press release also said that the average monthly premium for a Medicare Advantage plan is expected to decrease next year by 11%, from $23.60 this year to an estimated $21 next year.
CMS also reported that the that the average number of Medicare Advantage plan choices on a county-by-county basis is expected to increase next year to 47 plans per county compared with 39 per county this year.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More